logo
[breadcrumb_custom]

Tag: CTKB Stock

Stock

Behind Cytek BioSciences Inc’s 52-Week Range: Uncovering Opportunities for Investors

Cytek BioSciences Inc saw a rather unpredictable run in, in terms of market performance. The company’s stock reached its highest point at $12.31 on 05/04/23, while the lowest price for the same duration was marked at $3.80 on 11/08/23. 52-week price history of CTKB Stock Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Cytek BioSciences Inc’s current trading price is -49.23% away from its 52-week high, while its distance from the 52-week low is 64.47%. The stock’s price range during the 52-week period has remained

Stock

Cytek BioSciences Inc (CTKB) Stock: From Low to High in 52 Weeks

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Cytek BioSciences Inc’s current trading price is -42.57% away from its 52-week high, while its distance from the 52-week low is 86.05%. The stock’s price range for this period has been between $3.80 and $12.31 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 0.81 million for the day, a number notably higher than the average daily volume of 0.76 million over the last three months. The market performance of Cytek BioSciences Inc’s

Stock

A Closer Look at Cytek BioSciences Inc (CTKB) Stock Gains

Cytek BioSciences Inc experienced a rather shaky stock market performance. The highest value in the past year was recorded at $12.31 on 05/04/23 and the lowest value was $3.80 on 11/08/23. 52-week price history of CTKB Stock Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Cytek BioSciences Inc’s current trading price is -37.45% away from its 52-week high, while its distance from the 52-week low is 102.63%. The stock’s price range during the 52-week period has remained between $3.80 and $12.31. In the Healthcare sector,